🔴 Heron Therapeutics is trading 5.2% down today after revenue miss and guidance withdrawal

Heron Therapeutics is trading 5.2% down at $0.30, following recent pressure after second-quarter revenue missed expectations and management withdrew full-year 2026 guidance amid CINVANTI uncertainty.

• No fresh company-specific announcement was identified for August 18, 2026.
• The Nasdaq is down 1.38% and the S&P 500 is down 0.64%, suggesting broader risk-off sentiment.
• The stock fell from $0.32 on August 17 and remains highly volatile.